Our study further confirmed that IGF-1 can improve neuronal and synaptic function and clinical symptoms of RTT through modulating the PI3K-AKT-mTOR-S6 signaling pathway, consistent with previous studies (Costales and Kolevzon, 2016; Ip et al., 2018). This evidence concerns the gene RPS6 and Rett syndrome.